Lexatumumab
id:
lexatumumab-311-10696425
title:
Lexatumumab
text:
Lexatumumab is an experimental agonistic human monoclonal antibody against TRAIL-R2, intended for the treatment of cancer. HGS-ETR2 antibodies were generated by Human Genome Sciences through a collaboration with Cambridge Antibody Technology. Development was discontinued in 2015.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Lexatumumab
date created:
date modified:
2024-01-08T00:21:44Z
main entity:
{"identifier":"Q1112374","url":"https://www.wikidata.org/entity/Q1112374"}
image:
fields total:
13
integrity:
14